Breast Cancer, Familial
|
|
0.010 |
GeneticVariation
|
BEFREE |
A case-control study analysing a cohort of 348 German familial breast cancer cases and 960 corresponding controls showed no significant association of either Ile655Val (OR = 1.05, 95% CI = 0.82-1.34, P = 0.728) or Ala1170Pro (OR = 0.94, 95% CI = 0.74-1.20, P = 0.632) with familial breast cancer risk.
|
15550452 |
2005 |
Carcinoma of lung
|
|
0.010 |
GeneticVariation
|
BEFREE |
In this study, we investigated whether the four polymorphisms (-3444C>T, -1985 G>T, I655A A>G and P1170A C>G) of the HER-2 gene are associated with the risk of lung cancer in Korean populations.
|
19055823 |
2008 |
Malignant neoplasm of lung
|
|
0.010 |
GeneticVariation
|
BEFREE |
In this study, we investigated whether the four polymorphisms (-3444C>T, -1985 G>T, I655A A>G and P1170A C>G) of the HER-2 gene are associated with the risk of lung cancer in Korean populations.
|
19055823 |
2008 |
Primary malignant neoplasm of lung
|
|
0.010 |
GeneticVariation
|
BEFREE |
In this study, we investigated whether the four polymorphisms (-3444C>T, -1985 G>T, I655A A>G and P1170A C>G) of the HER-2 gene are associated with the risk of lung cancer in Korean populations.
|
19055823 |
2008 |
Malignant neoplasm of endometrium
|
|
0.010 |
GeneticVariation
|
BEFREE |
Subjects with BMI > or = 25 kg/m2 who carried rs1801200 AA, rs1801200 GA/GG, rs1810132 CT/CC, rs2517951 CT/TT and rs1058808 CG/GG genotype had significantly increased risk of endometrial cancer than subjects with a normal BMI (P for linear trend <0.05).
|
19438491 |
2009 |
Endometrial Carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
Subjects with BMI > or = 25 kg/m2 who carried rs1801200 AA, rs1801200 GA/GG, rs1810132 CT/CC, rs2517951 CT/TT and rs1058808 CG/GG genotype had significantly increased risk of endometrial cancer than subjects with a normal BMI (P for linear trend <0.05).
|
19438491 |
2009 |
Asthma
|
|
0.710 |
GeneticVariation
|
GWASDB |
Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations.
|
21804549 |
2011 |
Asthma
|
|
0.710 |
GeneticVariation
|
BEFREE |
ICSNPathway analysis identified four candidate causal SNPs, four genes, and 21 candidate causal pathways, which in total provided four hypothetical biologic mechanisms: (1) rs7192 (nonsynonymous coding) to HLA-DRA to 21 pathways, such as, the role of eosinophils in the chemokine network of allergy, Th1/Th2 differentiation, and asthma (nominal p ≤ 0.001, FDR p ≤ 0.01); (2) rs20541 (nonsynonymous coding) to IL13 to asthma and cytokines and inflammatory response (nominal p<0.001, FDR p ≤ 0.008); (3) rs1058808 (frameshift coding) to ERBB2 to transmembrane receptor activity (nominal p=0.001, FDR p=0.01); (4) rs17350764 (nonsynonymous coding (deleterious)) to OR52J3 to transmembrane receptor activity (nominal p=0.001, FDR p=0.01).
|
23200760 |
2013 |
Parkinson Disease
|
|
0.010 |
GeneticVariation
|
BEFREE |
Different signals or potency of the kinase activities resulting from the Ala1170Pro allele of HER2 may be associated with vulnerability to stress on dopaminergic neurons in PD.
|
23332978 |
2013 |
HER2-positive carcinoma of breast
|
|
0.020 |
GeneticVariation
|
BEFREE |
In a retrospective cohort study of 237 women with non-metastatic HER2-positive breast cancer treated with trastuzumab, traditional risk factors were assessed by review of medical records, alcohol use by an administered questionnaire to women (n=132), and HER2 polymorphisms (Ile655Val and Ala1170Pro) using TaqMan assays (n=73).
|
23749910 |
2013 |
Malignant neoplasm of breast
|
|
0.040 |
GeneticVariation
|
BEFREE |
ERBB2 Ala1170Pro was not associated with breast cancer susceptibility.
|
23900832 |
2013 |
Breast Carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
ERBB2 Ala1170Pro was not associated with breast cancer susceptibility.
|
23900832 |
2013 |
Breast Carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
HER2 rs1058808 and rs2517956 polymorphisms are associated with its protein expression in breast cancer.
|
26323365 |
2015 |
Malignant neoplasm of breast
|
|
0.040 |
GeneticVariation
|
BEFREE |
HER2 rs1058808 and rs2517956 polymorphisms are associated with its protein expression in breast cancer.
|
26323365 |
2015 |
Childhood Osteosarcoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
HER2 gene rs1136201 and rs1058808 polymorphisms and haplotype C-T-G-G may be related to osteosarcoma susceptibility in Chinese Han population, indicating that the interaction of gene polrmorphism plays an role in osteosarcoma risk.
|
26464710 |
2015 |
Osteosarcoma of bone
|
|
0.010 |
GeneticVariation
|
BEFREE |
HER2 gene rs1136201 and rs1058808 polymorphisms and haplotype C-T-G-G may be related to osteosarcoma susceptibility in Chinese Han population, indicating that the interaction of gene polrmorphism plays an role in osteosarcoma risk.
|
26464710 |
2015 |
Osteosarcoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
HER2 gene rs1136201 and rs1058808 polymorphisms and haplotype C-T-G-G may be related to osteosarcoma susceptibility in Chinese Han population, indicating that the interaction of gene polrmorphism plays an role in osteosarcoma risk.
|
26464710 |
2015 |
Malignant neoplasm of breast
|
|
0.040 |
GeneticVariation
|
BEFREE |
The underlying link between the Ala1170Pro SNP and HER2 positivity is not known, nor is the significance of HER2 overexpression and loss of heterozygosity in breast cancer.
|
26773371 |
2016 |
Breast Carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
The underlying link between the Ala1170Pro SNP and HER2 positivity is not known, nor is the significance of HER2 overexpression and loss of heterozygosity in breast cancer.
|
26773371 |
2016 |
HER2-positive carcinoma of breast
|
|
0.020 |
GeneticVariation
|
BEFREE |
This study demonstrates that only the Ala1170Pro polymorphism is associated with prognostic factors in HER2-positive breast cancer patients.
|
27788409 |
2016 |
Mammary Neoplasms
|
|
0.010 |
GeneticVariation
|
BEFREE |
However, we found significant differences in the distribution of Ile655Val (p = 0.03) and Ala1170Pro (p = 0.01) genotypes between normal breast and breast tumor tissues.
|
27788409 |
2016 |
Neoplasms
|
|
0.010 |
GeneticVariation
|
BEFREE |
Ala1170Pro polymorphism in normal breast tissue was associated with age at diagnosis (p = 0.007), tumor size (p = 0.004) and lymphovascular invasion (p = 0.06).
|
27788409 |
2016 |
Tumor Cell Invasion
|
|
0.010 |
GeneticVariation
|
BEFREE |
Ala1170Pro polymorphism in normal breast tissue was associated with age at diagnosis (p = 0.007), tumor size (p = 0.004) and lymphovascular invasion (p = 0.06).
|
27788409 |
2016 |
Prostate carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
In our previous study, we demonstrated that rs61552325 (Pro1140Ala) located in ERBB2 is strongly correlated to prostate cancer.
|
28422721 |
2017 |
Malignant neoplasm of prostate
|
|
0.010 |
GeneticVariation
|
BEFREE |
In our previous study, we demonstrated that rs61552325 (Pro1140Ala) located in ERBB2 is strongly correlated to prostate cancer.
|
28422721 |
2017 |